<DOC>
	<DOC>NCT02038660</DOC>
	<brief_summary>The purpose of this study is to evaluate long-term effectiveness and safety of patients with coronary disease treated with drug eluting balloon in real world practice.</brief_summary>
	<brief_title>Drug-Eluting Balloon Registry in Routine Clinical Practice</brief_title>
	<detailed_description />
	<mesh_term>Coronary Artery Disease</mesh_term>
	<mesh_term>Myocardial Ischemia</mesh_term>
	<mesh_term>Coronary Disease</mesh_term>
	<criteria>After pre dilatation residual stenosis 30% and less and also without vessel dissection interrupted blood flow Age 20 and more Treated with Balloon angioplasty Signed informed consent and agreed to follow protocol Allergy to paclitaxel, antiplatelet History of side effect to heparin, aspirin, thienopyridines History of bleeding tendency, coagulation disorder, blood transfusion reaction</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2016</verification_date>
	<keyword>Coronary Artery Disease</keyword>
	<keyword>Angioplasty, Balloon</keyword>
</DOC>